JAZALYSTO Trademark

Trademark Overview

On Wednesday, October 28, 2020, a trademark application was filed for JAZALYSTO with the United States Patent and Trademark Office. The USPTO has given the JAZALYSTO trademark a serial number of 79300623. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Wednesday, February 24, 2021. This trademark is owned by Glaxo Group Limited. The JAZALYSTO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
jazalysto

General Information

Serial Number79300623
Word MarkJAZALYSTO
Filing DateWednesday, October 28, 2020
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateWednesday, February 24, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateWednesday, February 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Sunday, March 14, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Saturday, March 13, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, January 15, 2021APPLICATION FILING RECEIPT MAILED
Monday, January 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 7, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 24, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

jazalysto pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological